Blurbs

Analysts Are Bullish on These Healthcare Stocks: Keros Therapeutics (KROS), Corcept Therapeutics (CORT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Keros Therapeutics (KROSResearch Report), Corcept Therapeutics (CORTResearch Report) and Alphatec Holdings (ATECResearch Report) with bullish sentiments.

Keros Therapeutics (KROS)

H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Keros Therapeutics today and set a price target of $100.00. The company’s shares closed last Friday at $48.64.

According to TipRanks.com, Fein is ranked 0 out of 5 stars with an average return of -12.0% and a 30.8% success rate. Fein covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Amylyx Pharmaceuticals Inc, and Deciphera Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Keros Therapeutics with a $90.00 average price target, a 74.4% upside from current levels. In a report issued on October 24, SVB Securities also reiterated a Buy rating on the stock with a $80.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Corcept Therapeutics (CORT)

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Corcept Therapeutics, with a price target of $33.00. The company’s shares closed last Friday at $25.55.

According to TipRanks.com, Ramakanth is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -13.5% and a 28.6% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals, Janux Therapeutics Inc, and Cellectar Biosciences.

Currently, the analyst consensus on Corcept Therapeutics is a Moderate Buy with an average price target of $34.00.

Alphatec Holdings (ATEC)

In a report released today, Sean Lee CFA from H.C. Wainwright maintained a Buy rating on Alphatec Holdings, with a price target of $20.00. The company’s shares closed last Friday at $9.24.

According to TipRanks.com, CFA has 0 stars on 0-5 stars ranking scale with an average return of -21.5% and a 21.4% success rate. CFA covers the Healthcare sector, focusing on stocks such as Monopar Therapeutics Inc, ThermoGenesis Holdings, and CASI Pharmaceuticals.

Alphatec Holdings has an analyst consensus of Strong Buy, with a price target consensus of $14.88, representing a 57.0% upside. In a report issued on November 4, Needham also reiterated a Buy rating on the stock with a $14.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on KROS:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More